Koyfin Home > Directory > Health Care > Amphastar Pharma > Cash from Financing Activities

Amphastar Pharma Cash from Financing Activities Chart (AMPH)

Amphastar Pharma annual/quarterly Cash from Financing Activities from 2014 to 2018.
  • Amphastar Pharma Cash from Financing Activities for the quarter ending September 09, 2018 was $18m a 104.50% increase of 19m year over year
  • Amphastar Pharma Cash from Financing Activities for the last 12 months ending September 09, 2018 was $7m a 205.96% increase of 15m year over year
  • Amphastar Pharma Annual Cash from Financing Activities for 2017 was $-8m a 192.51% decrease of -15m from 2016
  • Amphastar Pharma Annual Cash from Financing Activities for 2016 was $7m a 68.67% increase of 5m from 2015
  • Amphastar Pharma Annual Cash from Financing Activities for 2015 was $2m a -1,335.72% decrease of -30m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Cash from Financing Activities Data

09/2018$18m
06/2018$1m
03/2018$-11m
12/2017$-1m
09/2017$-6m
06/2017$10m
03/2017$-12m
12/2016$-1m
09/2016$13m
06/2016$2m

Annual AMPH Cash from Financing Activities Data

2017$-8m
2016$7m
2015$2m
2014$32m
2013$-9m